Novonesis A/S (NVZMY)
OTCMKTS · Delayed Price · Currency is USD
64.68
-0.60 (-0.92%)
May 13, 2025, 9:41 AM EDT

Novonesis Statistics

Total Valuation

Novonesis has a market cap or net worth of 30.30 billion. The enterprise value is 31.92 billion.

Market Cap 30.30B
Enterprise Value 31.92B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date May 8, 2025
Ex-Dividend Date Apr 7, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -8.56%
Shares Change (QoQ) +68.44%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 346.64M

Valuation Ratios

The trailing PE ratio is 61.15 and the forward PE ratio is 28.73.

PE Ratio 61.15
Forward PE 28.73
PS Ratio 6.91
PB Ratio 2.50
P/TBV Ratio 20.71
P/FCF Ratio 45.84
P/OCF Ratio 29.52
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.38, with an EV/FCF ratio of 48.28.

EV / Earnings 64.40
EV / Sales 7.07
EV / EBITDA 24.38
EV / EBIT 31.29
EV / FCF 48.28

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.15.

Current Ratio 1.66
Quick Ratio 1.03
Debt / Equity 0.15
Debt / EBITDA 1.44
Debt / FCF 2.78
Interest Coverage 11.41

Financial Efficiency

Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 7.25%.

Return on Equity (ROE) 6.97%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 7.25%
Return on Capital Employed (ROCE) 6.64%
Revenue Per Employee 414,444
Profits Per Employee 46,831
Employee Count 10,582
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.17% in the last 52 weeks. The beta is 0.55, so Novonesis's price volatility has been lower than the market average.

Beta (5Y) 0.55
52-Week Price Change +8.17%
50-Day Moving Average 61.17
200-Day Moving Average 61.66
Relative Strength Index (RSI) 58.13
Average Volume (20 Days) 17,641

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novonesis had revenue of 4.39 billion and earned 495.57 million in profits. Earnings per share was 1.71.

Revenue 4.39B
Gross Profit 2.31B
Operating Income 996.22M
Pretax Income 664.50M
Net Income 495.57M
EBITDA 1.28B
EBIT 996.22M
Earnings Per Share (EPS) 1.71
Full Income Statement

Balance Sheet

The company has 269.67 million in cash and 1.84 billion in debt, giving a net cash position of -1.57 billion.

Cash & Cash Equivalents 269.67M
Total Debt 1.84B
Net Cash -1.57B
Net Cash Per Share n/a
Equity (Book Value) 12.14B
Book Value Per Share 26.04
Working Capital 838.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -365.54 million, giving a free cash flow of 661.05 million.

Operating Cash Flow 1.03B
Capital Expenditures -365.54M
Free Cash Flow 661.05M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 52.73%, with operating and profit margins of 22.72% and 11.30%.

Gross Margin 52.73%
Operating Margin 22.72%
Pretax Margin 15.15%
Profit Margin 11.30%
EBITDA Margin 29.12%
EBIT Margin 22.72%
FCF Margin 15.07%

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.83%.

Dividend Per Share 0.54
Dividend Yield 0.83%
Dividend Growth (YoY) -4.48%
Years of Dividend Growth n/a
Payout Ratio 54.46%
Buyback Yield 8.56%
Shareholder Yield 9.39%
Earnings Yield 1.64%
FCF Yield 2.18%
Dividend Details

Stock Splits

The last stock split was on December 9, 2011. It was a forward split with a ratio of 5.

Last Split Date Dec 9, 2011
Split Type Forward
Split Ratio 5

Scores

Novonesis has an Altman Z-Score of 5.71.

Altman Z-Score 5.71
Piotroski F-Score n/a